PDCD1 and neoplasm: Lack of STK11 expression enhances neutrophil recruitment that inhibits CD8+ T cells and increases the expression of tumor cytokines, which reduces the efficacy of CD8+ T cells in anti-tumor immunity, and eventually promotes resistance to anti-PD-1/PD-L1 inhibitor [132,133].